1283495-02-2

Downstream Products

• 1352874-02-2 N-{4'-[3-(1H-Benzoimidazol-4-ylmethyl)-6-fluoro-2-imino-2,3-dihydro-benzoimidazol-1-yl]-5-chloro-biphenyl-2-yl}-acetamide 
• 1352874-64-6 4-[3-(2'-acetylamino-5'-chloro-biphenyl-4-yl)-5-fluoro-2-imino-2,3-dihydro-benzoimidazol-1-ylmethyl]-indole-1-carboxylic acid tert-butyl ester 
• 1352874-01-1 N-{5-chloro-4'-[6-fluoro-2-imino-3-(1H-indol-4-ylmethyl)-2,3-dihydro-benzoimidazol-1-yl]-biphenyl-2-yl}-acetamide 
• 1352874-65-7 N-[4'-(2-amino-6-fluoro-benzoimidazol-1-yl)-5-chloro-biphenyl-2-yl]-acetamide 
• 1352874-66-8 3-(4-bromo-phenyl)-1-(2-chloro-benzyl)-5-fluoro-1,3-dihydro-benzoimidazol-2-ylideneamine 

Relevant academic research and scientific papers

BIPHENYL SUBSTITUTED 1,3-DIHYDRO-BENZOIMIDAZOL-2-YLIDENEAMINE DERIVATIVES

The invention relates to new derivatives of formula (I), wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of one or more IGF-1R mediated disorders or diseases